Clinical Trials · NCT01673906
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
- Enrollment
- 142
- Start date
- Aug 2012
- Locations
- 21 sites, Austria, Italy
- Primary endpoint
- Accuracy of the diagnostic test.